LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • RBC Capital Markets Is Increasing Regeneron Pharmaceuticals (REGN) Q4 12 Rev. Estimate To 172.9 M From 164.5 M 1/10/2012 12:33:30 PM
  • RBC Capital Markets Is Raising Regeneron Pharmaceuticals (REGN) Q3 12 Rev. Estimate To 157.5 M From 144.2 M 1/10/2012 12:33:21 PM
  • RBC Capital Markets Is Raising Regeneron Pharmaceuticals (REGN) Q2 12 Rev. Estimate To 143.0 M From 129.5 M 1/10/2012 12:33:13 PM
  • RBC Capital Markets Is Increasing Regeneron Pharmaceuticals (REGN) Q1 12 Rev. Estimate To 168.0 M From 157.4 M 1/10/2012 12:33:03 PM
  • RBC Capital Markets Is Increasing Regeneron Pharmaceuticals (REGN) Q4 11 Rev. Estimate To 130.9 M From 106.9 M 1/10/2012 12:32:56 PM
  • RBC Capital Markets Is Increasing Regeneron Pharmaceuticals (REGN) 2013 Rev. Estimate To 771.5 M From 765.9 M 1/10/2012 12:32:44 PM
  • RBC Capital Markets Is Raising Regeneron Pharmaceuticals (REGN) 2012 Rev. Estimate To 641.5 M From 595.7 M 1/10/2012 12:32:37 PM
  • RBC Capital Markets Is Increasing Regeneron Pharmaceuticals (REGN) 2011 Rev. Estimate To 453.7 M From 429.7 M 1/10/2012 12:32:30 PM
  • Robert W. Baird Is Increasing Regeneron Pharmaceuticals (REGN) FY12 Estimate To -0.89 From -1.48 1/10/2012 8:22:27 AM
  • Robert W. Baird Is Raising Regeneron Pharmaceuticals (REGN) FY11 Estimate To -2.33 From -2.55 1/10/2012 8:21:49 AM
  • Robert W. Baird Lifts Regeneron Pharmaceuticals (REGN) To Outperform From Neutral With $81 up from $56 Price Target 1/10/2012 8:01:30 AM
  • Robert W. Baird Reiterates Regeneron Pharmaceuticals (REGN) At Neutral With $56 Price Target 12/6/2011 7:24:54 AM
  • Robert W. Baird Reiterates Regeneron Pharmaceuticals (REGN) At Neutral With $56 Price Target 12/1/2011 7:45:45 AM
  • RBC Capital Markets Is Lowering Regeneron Pharmaceuticals (REGN) 2013 Rev. Estimate To 765.9 M From 771.6 M 11/21/2011 11:28:40 AM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap